These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 4001150)

  • 1. [Molecular galenical evaluation of the conventional handling of solids in homeopathy].
    Hüttenrauch R; Fricke S
    Pharmazie; 1985 Feb; 40(2):129-30. PubMed ID: 4001150
    [No Abstract]   [Full Text] [Related]  

  • 2. [The evaluation of non-isothermal short-term tests of drug solutions].
    Kersten D; Göber B
    Pharmazie; 1984 Aug; 39(8):541-6. PubMed ID: 6504977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of differential thermoanalysis in pharmacy].
    Wollmann H; Braun V
    Pharmazie; 1983 Jan; 38(1):5-21. PubMed ID: 6342006
    [No Abstract]   [Full Text] [Related]  

  • 4. Factorial designs in pharmaceutical preformulation studies. II. Studies on drug stability and compatibility in the solid state.
    Ahlneck C; Waltersson JO
    Acta Pharm Suec; 1986; 23(3):139-50. PubMed ID: 3766159
    [No Abstract]   [Full Text] [Related]  

  • 5. Issues in evaluation of bioanalytical method selectivity and drug stability.
    Dadgar D; Burnett PE
    J Pharm Biomed Anal; 1995 Dec; 14(1-2):23-31. PubMed ID: 8833963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identity tests of chemical drugs in CsL 3].
    Zahradnícek M
    Cesk Farm; 1971 Mar; 20(2):63-74. PubMed ID: 5550005
    [No Abstract]   [Full Text] [Related]  

  • 7. [Control of the acceptability and stability of proprietary drugs].
    Braidotti L; Crivellaro GB
    Farmaco Prat; 1968 Oct; 23(10):509-41. PubMed ID: 5721577
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening chemical and physical stability of drug substances.
    Berglund M; Byström K; Pérsson B
    J Pharm Biomed Anal; 1990; 8(8-12):639-43. PubMed ID: 2100600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stability and purity of drugs chemically determined].
    Pellerin F
    Farmaco Prat; 1967 Oct; 22(10):529-52. PubMed ID: 5612779
    [No Abstract]   [Full Text] [Related]  

  • 10. [Shelf-life estimation of pharmaceutical products by matrixing].
    Yoshioka S; Aso Y; Kojima S
    Eisei Shikenjo Hokoku; 1996; (114):143-4. PubMed ID: 9037887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Some aspects of drug-pharmaceutic aid interactions and their effects].
    Keipert S
    Pharmazie; 1984 Sep; 39(9):644-7. PubMed ID: 6505003
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of a semi-automated chemical stability system to analyze solution based formulations in support of discovery candidate selection.
    Hitchingham L; Thomas VH
    J Pharm Biomed Anal; 2007 Jan; 43(2):522-6. PubMed ID: 16996236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug effects in clinical chemistry. Part 2. Guidelines for evaluation of analytical interference.
    Galteau MM; Siest G
    J Clin Chem Clin Biochem; 1984 Mar; 22(3):275-9. PubMed ID: 6726127
    [No Abstract]   [Full Text] [Related]  

  • 14. Achieving polymorph selectivity in the crystallization of pharmaceutical solids: basic considerations and recent advances.
    Reutzel-Edens SM
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):806-15. PubMed ID: 17117688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polymorphy of drugs. II].
    Hoeke M
    Pharm Weekbl; 1969 Oct; 104(44):1386. PubMed ID: 5352089
    [No Abstract]   [Full Text] [Related]  

  • 16. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A product standards form for new radipharmaceuticals.
    Warbick A
    Am J Hosp Pharm; 1974 Feb; 31(2):165-6. PubMed ID: 4815850
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of gas chromatography and mass spectrometry in forensic chemistry for the demonstration of drugs and their metabolites].
    Chundela B; Slechtová R
    Beitr Gerichtl Med; 1974; 32():206-14. PubMed ID: 4468785
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of prediction methods to estimate true density of active pharmaceutical ingredients.
    Cao X; Leyva N; Anderson SR; Hancock BC
    Int J Pharm; 2008 May; 355(1-2):231-7. PubMed ID: 18242023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of the molar volume of a compound in solution].
    Dubost JP; Demau M
    Ann Pharm Fr; 1986; 44(3):197-201. PubMed ID: 3800256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.